ReviewDiabetology & metabolic syndrome2025

Evaluating the overall renal outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with chronic kidney disease (CKD).

Min-Jia Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.